NEW ORLEANS -- Adding the PCSK9 inhibitor evolocumab (Repatha) to stable lipid-lowering therapy reduced major adverse cardiac ...

In a world first, Lipsman and his team in Sunnybrook’s Hurvitz Brain Sciences Program non-invasively breached the blood-brain ...

A delegation from the Ministry of Health and Prevention (MoHAP) has concluded an official visit to Spain aimed at ...

Our first approach should be to check the Startup paths. The first approach towards resolving the issue in the discussion should be to eliminate the possibility or third-party software interfering ...